1. There is no European strategy specifically on uterine fibroids. In terms of chronic diseases more generally, the Commission has launched a reflection process on chronic diseases with Member States. While not disease-specific, the objective of this process is to identify gaps and areas of added value for potential EU action to address chronic diseases.

The Commission is aware of the burden of uterine fibroids and its impact on women. Although no specific research related to uterine fibroids is currently supported by the Seventh Framework Programme for Research and Technological Development (FP7, 2007‑2013), significant resources are devoted to research on malignant cancers of female reproductive organs, including cancers of cervix uteri (EUR 21 million) and ovarian cancers (EUR 13 million). Overall, some EUR 230 million has been allocated to support research on female cancers (breast, cervix and ovary) for the period 2007‑2012.

2. There is no European data on the number of women affected by uterine fibroids.